Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

NCT00362856 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: larazotide acetate
DRUG: Placebo

Sponsor

9 Meters Biopharma, Inc.